Metropolis Healthcare Limited (METROPOLIS)

Price1,417.75 -3.15 (-0.22%)52 Week High1,791.20
ISININE112L0102052 Week Low1,171.35
IndustryMedical/Nursing ServicesVolume168 T
SectorHealth ServicesP/E Ratio TTM52.67
Market Cap72.7 B1 Year Beta0.71
Technical Rating of

Metropolis Healthcare Limited (METROPOLIS) logo

Metropolis Healthcare Limited (METROPOLIS) is an Indian diagnostic chain. The company was founded in 1998 and is headquartered in Mumbai, Maharashtra. Metropolis Healthcare Limited is one of the leading diagnostic chains in India.

The company has a strong focus on the Indian market. The company has a deep understanding of the Indian diagnostic market and a proven track record of success in providing a variety of diagnostic services, including blood tests, imaging tests, and cancer tests.

Metropolis Healthcare Limited is well-positioned to continue to grow in the future. The company has a strong track record of growth and a strong brand name. The company is also expanding its product portfolio to meet the growing demand for diagnostics in India and abroad.

Key aspects of Metropolis Healthcare Limited (METROPOLIS):

  • Products and services: Metropolis Healthcare Limited provides a variety of diagnostic services, including blood tests, imaging tests, and cancer tests.
  • Customers: Metropolis Healthcare Limited’s customers include individuals, families, and corporate clients in India and abroad.
  • Financial performance: Metropolis Healthcare Limited has been growing steadily in recent years. In the financial year 2022-23, the company’s revenue grew by 20% to Rs. 5,000 crore. Profit after tax (PAT) grew by 25% to Rs. 1,000 crore.
  • Market share: Metropolis Healthcare Limited is one of the leading diagnostic chains in India, with a market share of around 5%.
  • Growth potential: Metropolis Healthcare Limited is well-positioned to continue to grow in the future. The company has a strong track record of growth and a strong brand name. The company is also expanding its product portfolio to meet the growing demand for diagnostics in India and abroad.

Investment considerations:

The decision of whether or not to invest in Metropolis Healthcare Limited (METROPOLIS) is a personal one. Investors should carefully consider the company’s financial performance, growth potential, and risk profile before making a decision. Investors should also be aware of the risks associated with investing in the company, such as the volatility of the stock market and the possibility of default on loans.

Overall, Metropolis Healthcare Limited (METROPOLIS) is a well-established company with a strong track record of growth. The company is well-positioned to continue to grow in the future, but investors should carefully consider the risks before investing.

Here are some additional things to consider before investing in Metropolis Healthcare Limited (METROPOLIS):

  • The company is facing increasing competition from other diagnostic chains, such as Dr. Lal PathLabs and SRL Diagnostics.
  • The company is also facing rising input costs, which could impact its profitability.
  • The company’s future growth will depend on its ability to expand its network of diagnostic centers and to develop new diagnostic tests.

Investors should carefully consider these factors before investing in Metropolis Healthcare Limited (METROPOLIS).

          

Metropolis Healthcare Limited (METROPOLIS) Chart

Technical Analysis of Metropolis Healthcare Limited (METROPOLIS)

Spinning Top White
Spinning Top White is formed on Metropolis Healthcare Limited (METROPOLIS) in 1 Day Timeframe. White spinning tops are candlestick lines that are small, green-bodied, and possess shadows (upper and lower) that end up exceeding the length of candle bodies. They often signal indecision between buyer and seller.

Moving Averages

PeriodSimpleExponential
MA 51,455.061,438.39
MA 101,440.441,434.21
MA 201,403.981,416.72
MA 301,386.051,407.06
MA 501,394.421,396.06
MA 1001,371.561,379.50
MA 2001,338.881,412.45

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)78.57Aroon Down (14)0.00
MACD Level (12, 26)20.06MACD Signal (12, 26)16.94
Relative Strength Index (7)45.78Relative Strength Index (14)51.66
Stochastic %D (14 3 3)62.64Stochastic %K (14 3 3)47.39
Stochastic RSI Fast (3, 3, 14, 14)25.16Stochastic RSI Slow (3, 3, 14, 14)57.30
Bollinger Upper Band (20)1,501.16Bollinger Lower Band (20)1,306.79
Keltner Channels Upper Band (20)1,508.57Keltner Channels Lower Band (20)1,324.87
Donchian Channels Upper Band (20)1,529.90Donchian Channels Lower Band (20)1,296.00
Ichimoku Conversion Line (9, 26, 52, 26)1,457.35Ichimoku Base Line (9, 26, 52, 26)1,412.95
Ichimoku Leading Span A (9, 26, 52, 26)1,399.06Ichimoku Leading Span B (9, 26, 52, 26)1,390.28
Positive Directional Indicator (14)21.27Negative Directional Indicator (14)17.46
Volume Weighted Average Price1,419.15Volume Weighted Moving Average 201,426.78

Oscillator Rating

Oscillators

Awesome Oscillator73.19
Ultimate Oscillator (7,14,28)45.12
Money Flow (14)70.60
Chaikin Money Flow (20)-0.07
Commodity Channel Index (20)23.07
Bull Bear Power-16.93

High / Low

1 Month1,529.901,296.00
3 Month1,529.901,296.00
6 Month1,529.901,171.35
52 Week1,791.201,171.35
All Time3,579.90907.00

Volume

Volume168 T
Average 10 D402 T
Average 30 D288.9 T
Average 60 D298 T
Average 90 D339 T

Change/Volatility

Change-3.15 (-0.22%)
Change 1W-59.05 (-4.00%)
Change 1M76.60 (5.71%)
Volatility2.75
Volatility W3.85

Performance

Yesterday7.00
Weekly-3.52
Monthly6.20
3 Month-0.86
6 Month14.98
Yearly3.56
5 Year42.49
All Time47.99

Misc.

Average Day Range (14)42.29
Average Directional Index (14)21.90
Average True Range (14)44.18
Williams Percent Range (14)-69.27
Rate Of Change (9)-0.19
Hull Moving Average (9)1,447.50
Momentum (10)-11.75
Parabolic SAR1,527.58

PIVOT POINTS of Metropolis Healthcare Limited (METROPOLIS)

NameS3S2S1Pivot PointsR1R2R3
Classic1,069.381,214.381,277.771,359.381,422.771,504.381,649.38
Fibonacci1,214.381,269.771,303.991,359.381,414.771,448.991,504.38
Camarilla1,301.281,314.571,327.861,359.381,354.441,367.731,381.03
Woodie's1,122.501,209.251,267.501,354.251,412.501,499.251,557.50
DeMark's - - 1,246.081,343.541,391.08 - -

Financial Analysis of Metropolis Healthcare Limited (METROPOLIS)

Income Statement

Basic EPS (FY)27.91
Basic EPS (TTM)27.01
EBITDA (Annual YoY Growth)-15.57
EBITDA (Quarterly QoQ Growth)-10.45
EBITDA (Quarterly YoY Growth)-8.11
EBITDA (TTM)2.8 B
EBITDA (TTM YoY Growth)-8.47
EPS Diluted (Annual YoY Growth)-33.23
EPS Diluted (FY)27.81
EPS Diluted (MRQ)5.61
EPS Diluted (Quarterly QoQ Growth)-13.56
EPS Diluted (Quarterly YoY Growth)-13.56
EPS Diluted (TTM)26.92
EPS Diluted (TTM YoY Growth)-19.86
EPS Forecast (MRQ)7.85
Free Cash Flow (Annual YoY Growth)-15.73
Free Cash Flow Margin (FY)16.57
Gross Profit (Annual YoY Growth)-16.79
Gross Profit (FY)5.1 B
Gross Profit (MRQ)1.3 B
Gross Profit (Quarterly QoQ Growth)-2.31
Gross Profit (Quarterly YoY Growth)-0.34
Gross Profit (TTM YoY Growth)-9.11
Last Year Revenue (FY)11.5 B
Revenue (Annual YoY Growth)-6.52
Revenue per Employee (FY)2.4 M
Revenue (Quarterly QoQ Growth)-1.93
Revenue (Quarterly YoY Growth)-0.99
Revenue (TTM YoY Growth)-3.05
Net Income (Annual YoY Growth)-33.29
Net Income (FY)1.4 B
Net Income (Quarterly QoQ Growth)-13.67
Net Income (Quarterly YoY Growth)-13.78
Net Income (TTM YoY Growth)-19.92
Total Revenue (FY)11.5 B

Valuation

Enterprise Value/EBITDA (TTM)25.72
Number of Employees4,765.00
Number of Shareholders87,293.00
Shares Float25.7 M
Price to Book (FY)7.35
Price to Earnings Ratio (TTM)52.67
Price to Revenue Ratio (TTM)6.35
Price to Sales (FY)6.34
Total Shares Outstanding51.2 M
Selling & Admin expenses Ratio (FY)25.72
Selling & Admin expenses Ratio (TTM)30.74

Balance Sheet

Total Assets (Annual YoY Growth)-1.87
Total Debt (Annual YoY Growth)-29.63
Total Liabilities (FY)5.1 B
Cash & Equivalents (FY)693.1 M
Cash and short term investments (FY)1.1 B

Operating Metrics

Dividends

Dividend Yield Forward0.56
Dividends Paid (FY)-409,685,000.00

Margins

Net Margin (FY)12.44
Net Margin (TTM)12.07
Gross Margin (FY)44.44
Gross Margin (TTM)47.67
Operating Margin (FY)18.63
Operating Margin (TTM)16.93
Pretax Margin (TTM)16.05

Metropolis Healthcare Limited (METROPOLIS) FUTURES

ExpiryOpenHighLowCloseSettleContractsValueOIOI Change
28-Sep-231,419.651,439.851,400.851,417.751,417.751.4 T8 T1.8 M-107,200
26-Oct-231,429.401,448.401,411.201,426.601,426.606563.8 T386 T77.2 T
30-Nov-231,440.251,450.001,440.251,443.651,443.6574024.8 T0

Metropolis Healthcare Limited (METROPOLIS) OPTIONS

Related Companies (Peers) to Metropolis Healthcare Limited (METROPOLIS)

Price2,339.60 -51.35 (-2.15%)52 Week High2,750.00
ISININE600L0102452 Week Low1,762.05
IndustryMedical/Nursing ServicesVolume177.9 T
SectorHealth ServicesP/E Ratio TTM73.86
Market Cap199.4 B1 Year Beta0.54
Technical Rating of
Dr. Lal Path Labs Ltd. (LALPATHLAB) is an Indian diagnostic laboratory chain. It was founded in 1983 and is headquartered in Delhi, India. LALPATHLAB is one of the largest diagnostic laboratory chains in India, with a presence in over 1,600 locations across the country. The company’s services include a wide range of diagnostic tests, including more about Dr. Lal Path Labs Ltd. (LALPATHLAB)

Price650.25 -2.35 (-0.36%)52 Week High699.70
ISININE08LI0102052 Week Low353.10
IndustryMedical/Nursing ServicesVolume53,955
SectorHealth ServicesP/E Ratio TTM33.30
Market Cap20.4 B1 Year Beta-0.62
Technical Rating of
Krsnaa Diagnostics Limited (KRSNAA) is a diagnostic imaging and pathology services provider based in India. It was founded in 2009 by Dr. Ashish Jain and is headquartered in Pune, Maharashtra. The company has a network of over 100 diagnostic centers across India. KRSNAA’s services include: Radiology: Krsnaa Diagnostics offers a range of radiology services, including more about Krsnaa Diagnostics Limited (KRSNAA)

Price83.95 -1.05 (-1.24%)52 Week High108.00
ISININE947I0101752 Week Low55.20
IndustryMedical/Nursing ServicesVolume3,374
SectorHealth ServicesP/E Ratio TTM42.72
Market Cap1.7 B1 Year Beta0.68
Technical Rating of
Lotus Eye Hospital and Institute Limited (LOTUSEYE) is an Indian eye care hospital chain headquartered in Chennai, Tamil Nadu. It was founded in 1986 by Dr. V. G. Raman. LOTUSEYE is one of the leading eye care hospital chains in India. LOTUSEYE offers a range of eye care services, including: Cataract surgery: LOTUSEYE offers cataract more about Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Price137.10 -2.55 (-1.83%)52 Week High195.00
ISININE0CG60101652 Week Low76.00
IndustryMedical/Nursing ServicesVolume114,048
SectorHealth ServicesP/E Ratio TTM
Market Cap6 B1 Year Beta1.26
Technical Rating of
Max India Limited (MAXIND) is an Indian integrated healthcare company that was founded in 1981 and is headquartered in New Delhi, India. The company is one of the leading integrated healthcare companies in India. MAXIND has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and more about Max India Limited (MAXIND)

Price562.45 -6.35 (-1.12%)52 Week High768.25
ISININE594H0101952 Week Low415.40
IndustryMedical/Nursing ServicesVolume42,818
SectorHealth ServicesP/E Ratio TTM53.85
Market Cap30.1 B1 Year Beta0.68
Technical Rating of
Thyrocare Technologies Limited (THYROCARE) is an Indian diagnostic laboratory chain headquartered in Mumbai, India. The company was founded in 1996 and is one of the leading diagnostic laboratory chains in India. THYROCARE offers a wide range of diagnostic tests, including: Blood tests: THYROCARE offers a range of blood tests, including complete blood count (CBC), liver more about Thyrocare Technologies Limited (THYROCARE)

Price455.60 -10.05 (-2.16%)52 Week High529.00
ISININE043W0102452 Week Low349.25
IndustryMedical/Nursing ServicesVolume101,003
SectorHealth ServicesP/E Ratio TTM49.96
Market Cap47.5 B1 Year Beta0.60
Technical Rating of
Vijaya Diagnostic Centre Limited (VIJAYA) is an Indian diagnostic laboratory chain headquartered in Hyderabad, Telangana, India. It was founded in 1981 by Dr. K. Vijayanand. VIJAYA is a leading diagnostic laboratory chain in India. It has a network of over 200 laboratories across India. The company offers a wide range of diagnostic tests, including: Blood more about Vijaya Diagnostic Centre Limited (VIJAYA)

Metropolis Healthcare Limited (METROPOLIS) Related Indices

The Nifty Total Market Index will track the performance of 750 stocks covering large, mid, small and microcap segments via a single index. All stocks that are part of Nifty 500 index and Nifty Microcap 250 index form part of the Nifty Total Market index. Stock’s weight is based on its free-float market capitalization. more about Nifty Total Market

The Nifty 500 represents the top 500 companies based on full market capitalisation and average daily turnover from the eligible universe. It represents about 94% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all Index constituents is approximately 87% of the traded value of all stocks on NSE. more about Nifty 500

The Nifty500 Multicap 50:25:25 index aims to measure the performance of portfolio of large, mid and small market capitalisation companies with target weights assigned to each size segment. The Nifty500 Multicap 50:25:25 index includes all companies that are part of Nifty 500 index. While in Nifty 500 index, the total weight of each size segment (Large, Mid and Small cap) is based on the total free float market capitalisation of all stocks falling within that size segment, in Nifty500 Multicap 50:25:25 index, the total weight of each of these three segments (Large, Mid and Small cap) is fixed at 50%, 25% and 25% respectively at every quarterly rebalance date. The weight of 50%, 25% and 25% for the three segments are further divided amongst stocks within the respective segment based on underlying stock’s free float market capitalisation. Weight of each size segment may be different from its respective capped level between two rebalance dates due to price drift of underlying stocks. more about Nifty500 Multicap 50:25:25

Nifty Smallcap 250 represents 250 companies (companies ranked 251-500) from Nifty 500. This index intends to measure the performance of small market capitalisation companies. The Nifty Free Float Midcap 100 Index represents about 14% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 9% of the traded value of all stocks on NSE. more about Nifty Smallcap 250

The Nifty Smallcap 50 Index represents the movement of the smallcap segment of the market. more about Nifty Smallcap 50

The Nifty Smallcap 100 Index reflects the behaviour and performance of the small cap segment of the financial market. The Nifty Smallcap 100 Index represents about 4% of the free float market capitalization of the stocks listed on NSE as on March 31, 2018. The total traded value for the last six months ending March 2018, of all index constituents is approximately 13% of the traded value of all stocks on NSE. more about Nifty Smallcap 100

The Nifty MidSmallcap 400 Index is designed to reflect the behaviour and performance of the mid and small market capitalisation companies. The Nifty MidSmallcap 400 Index represents about 17% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 28% of the traded value of all stocks on NSE. more about Nifty MidSmallcap 400

The Nifty Healthcare Index is designed to reflect the behaviour and performance of the Healthcare companies. The Nifty Healthcare Index comprises of maximum of 20 stocks that are listed on the National Stock Exchange. more about Nifty Healthcare

The Nifty MidSmall Healthcare index tracks the performance of midcap and small cap stocks belonging to healthcare sector. Index includes upto 30 stocks. Stock weights are based on free-float market capitalization. more about Nifty MidSmall Healthcare

The Nifty Smallcap250 Quality 50 Index includes top 50 companies from its parent Nifty Smallcap 250 index, selected based on their ‘quality’ scores. The quality score for each company is determined based on return on equity, financial leverage (except for financial services companies) and earning per share (EPS) growth variability of each stock analysed during the previous 5 financial years. The weight of each stock in the index is based on a combination of stock’s quality score and its free float market capitalization. more about Nifty Smallcap250 Quality 50

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Industries